Myasthenia Gravis, Generalized Clinical Trials

33 clinical trials for Myasthenia Gravis, Generalized across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis — RECRUITING
• AXIS MG Patient Registry — RECRUITING
• Study of Aritinercept in Patients With Generalized Myasthenia Gravis — RECRUITING · PHASE1
• A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis — RECRUITING · PHASE2
• PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis — RECRUITING
• A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) — RECRUITING · PHASE3
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — RECRUITING
• Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod — RECRUITING · PHASE4
• Markers of Favorable Response to Complement Inhibitors Therapy — RECRUITING
• Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) — RECRUITING · PHASE3
• Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis — RECRUITING · PHASE2
• Myasthenia Gravis Foundation of America Global MG Patient Registry — RECRUITING
• Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) — ACTIVE_NOT_RECRUITING · PHASE2
• The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis — ACTIVE_NOT_RECRUITING · PHASE1
• Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360 — NOT_YET_RECRUITING · NA
• Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG — NOT_YET_RECRUITING
• Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis — NOT_YET_RECRUITING
• Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study — COMPLETED · PHASE1
• Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis — COMPLETED · PHASE3
• A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis — WITHDRAWN
• Study of Telitacicept in Generalized Myasthenia Gravis — COMPLETED · PHASE3
• Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. — NOT_YET_RECRUITING · PHASE1
• A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) — COMPLETED · PHASE3
• Markers of Favorable Response to FcRn Inhibitors(INFORM) — OTHER
• Predictors and Prognostic Factors of Myasthenia Gravis Outcome — OTHER
• Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG — COMPLETED · PHASE3
• Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis — OTHER · PHASE2
• Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis — COMPLETED · PHASE2
• A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis — COMPLETED · PHASE2
• A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis — WITHDRAWN · PHASE2
• A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis — COMPLETED · PHASE3

Refine this search